Der Vortrag „Sekundäre dilatative Kardiomyopathie“ von Joseph Alpert, MD ist Bestandteil des Kurses „Kardiomyopathie“.
Which of the following findings is less likely in a patient with ischemic dilated cardiomyopathy without significant obstructive valvulopathy?
Which of the following drugs is most likely to cause dilated cardiomyopathy at therapeutic levels?
Which of the following is not a treatment option for dilated cardiomyopathy?
5 Sterne |
|
5 |
4 Sterne |
|
0 |
3 Sterne |
|
0 |
2 Sterne |
|
0 |
1 Stern |
|
0 |